Resonance Health Ltd. appointed Prof. John Olynyk as Chief Medical Officer. Prof. Olynyk is an internationally recognised leader in liver-related diseases including iron-metabolism disorders, hemochromatosis, liver-injury, hepatocellular carcinoma, and non-alcoholic fatty liver disease. Prof. Olynyk's current roles include consultant Hepatologist in the Dept of Gastroenterology at Fiona Stanley Hospital (formerly Head of Gastroenterology, 2015-2020), Dean of Clinical Research & Professor of Translational Medicine at ECU, Theme Lead of Health Research at ECU, Member of the Joint Scientific Committee of Haemochromatosis International, and Medical Advisor to both Haemochromatosis Australia and Red Cross Lifeblood Australia.